Cargando…
Kynurenic Acid Levels are Increased in the CSF of Alzheimer’s Disease Patients
Kynurenic acid (KYNA) is a product of the tryptophan (TRP) metabolism via the kynurenine pathway (KP). This pathway is activated in neurodegenerative disorders, such as Alzheimer´s disease (AD). KYNA is primarily produced by astrocytes and is considered neuroprotective. Thus, altered KYNA levels may...
Autores principales: | González-Sánchez, Marta, Jiménez, Javier, Narváez, Arantzazu, Antequera, Desiree, Llamas-Velasco, Sara, Herrero-San Martín, Alejandro, Molina Arjona, Jose Antonio, López de Munain, Adolfo, Lleó Bisa, Alberto, Marco, M.-Pilar, Rodríguez-Núñez, Montserrat, Pérez-Martínez, David Andrés, Villarejo-Galende, Alberto, Bartolome, Fernando, Domínguez, Elena, Carro, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226436/ https://www.ncbi.nlm.nih.gov/pubmed/32276479 http://dx.doi.org/10.3390/biom10040571 |
Ejemplares similares
-
Increased YKL-40 but Not C-Reactive Protein Levels in Patients with Alzheimer’s Disease
por: Blanco-Palmero, Víctor Antonio, et al.
Publicado: (2021) -
Annexin A5 prevents amyloid-β-induced toxicity in choroid plexus: implication for Alzheimer’s disease
por: Bartolome, Fernando, et al.
Publicado: (2020) -
Decreased salivary lactoferrin levels are specific to Alzheimer's disease
por: González-Sánchez, Marta, et al.
Publicado: (2020) -
Choroid Plexus Aquaporins in CSF Homeostasis and the Glymphatic System: Their Relevance for Alzheimer’s Disease
por: Municio, Cristina, et al.
Publicado: (2023) -
Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin
por: Carro, Eva, et al.
Publicado: (2017)